Press Release: ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors
ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha…
Press release: Transparency Notification from Shareholder
Transparency Notification from Shareholder Ghent, Belgium – 13 October 2025 – Sequana…
JNH PRESS Holds Completion Ceremony for Second Plant, Accelerating Leadership in Global Innovative Press Technology
SEOUL, South Korea, Sept. 26, 2025 /PRNewswire/ -- JNH PRESS, a leading…
Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation
Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment…
Press release: Availability of the Q3 2025 Aide mmoire
Availability of the Q3 2025 Aide mémoire Paris, France – September 24,…
Press Release Biocartis NV: Biocartis Receives FDA Approval for the Idylla CDx MSI Test
PRESS RELEASE - 09/15/2025, 09:00 AM EDT Biocartis Receives FDA Approval for…
Carnival and Telluride SUV named 2025 category winners by New England Motor Press Association
The 2025 Carnival MPV and 2025 Telluride SUV each received 2025 Winter…
Press Release: Q2: double-digit sales and solid business EPS growth. 2025 sales guidance is now high single-digit growth, at upper end of range
Q2: double-digit sales and solid business EPS growth. 2025 sales guidance is…
Press Release: Sanofis Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma
Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly…
Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES…
